|
|
| 1. |
Neurodegenerative diseases and oxidative stress
Kevin J Barnham, Colin L. Masters and Ashley I Bush.
Nature Reviews Drug Discovery 3, 205-214 (2004)
|
| 2. |
Gamma-Glutamylcysteine Ethyl Ester-Induced Up-Regulation of Glutathione Protects Neurons Against Aß (1-42)-Mediated Oxidative Stress and Neurotoxicity: Implications for Alzheimer's Disease
Debra Boyd-Kimball, Rukhsana Sultana, Hafz Mohmmad Abdul and D. Allan Butterfield
Journal of Neuroscience Research 79:700-706 (2005)
|
| 3. |
Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease
Ilaria Guidi, Daniela Galimberti, Silvia Lonati, Cristina Novembrino, Fabrizia Bamonti, Marco Tiriticco, Chiara Fenoglio, Eliana Venturelli, Pierluigi Baron, Nereo Bresolin, Elio Scarpini
Neurobiology of Aging. 2006;27(2) 262-269.
|
| 4. |
Evidence of increased oxidative damage in subjects with mild cognitive impairment
JN Keller, FA Schmitt, SW Scheff, Q Ding, Q Chen, DA Butterfield and WR Markesbery
Neurology 2005;64:1152-1156.
|
| 5. |
In-vivo glutathione elevation protects against hydroxyl free radical-induced protein oxidation in rat brain
C.B. Pocernich M. La Fontaine D.A. Butterfield
Neurochemistry International 36 (2000) 185-191 www.elsevier.com/locate/neuint
|
|
|
